Rapid Micro Biosystems Inc reports results for the quarter ended June 30 - Earnings Summary

• Rapid Micro Biosystems Inc RPID.OQ reported a quarterly adjusted loss of 27 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -29 cents. The mean expectation of four analysts for the quarter was for a loss of 25 cents per share. Wall Street expected results to range from -27 cents to -24 cents per share.

• Revenue rose 9.7% to $7.26 million from a year ago; analysts expected $7.03 million.

• Rapid Micro Biosystems Inc's reported EPS for the quarter was a loss of 27 cents​.

• The company reported a quarterly loss of $11.86 million.

• Rapid Micro Biosystems Inc shares had fallen by 5.5% this quarter and gained 262.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Rapid Micro Biosystems Inc is $8.00, about 59.3% above its last closing price of $3.26

This summary was machine generated from LSEG data August 12 at 01:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)